ALL

Showing 26 - 47 of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (Rapamycin + high dose etoposide and cytarabine)

Terminated
  • ALL
  • +3 more
  • Rapamycin + high dose etoposide and cytarabine
  • Philadelphia, Pennsylvania
    University of Pennsylvania Abramson Cancer Center
Apr 15, 2020

Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)

Completed
  • Hodgkin Lymphoma
  • +8 more
  • Stem cell transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019

AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)

Completed
  • AML
  • +11 more
  • Boston, Massachusetts
    Boston Children's Hospital
Oct 31, 2019

Breast Cancer, ALL, Lung Cancer Trial in Belgium (Implementation of a care pathway)

Recruiting
  • Breast Cancer
  • +5 more
  • Implementation of a care pathway
  • Turnhout, Antwerpen, Belgium
  • +3 more
Apr 15, 2019

Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)

Completed
  • Relapsed/Refractory AML
  • +5 more
  • Plerixafor Dose Escalation
  • Phoenix, Arizona
  • +8 more
Sep 5, 2018

Methotrexate Induced Gastrointestinal Intolerance in Juvenile

Completed
  • Juvenile Idiopathic Arthritis
  • ALL
    • (no location specified)
    Aug 16, 2018

    Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

    Completed
    • Acute Lymphoblastic Leukemia
    • +9 more
    • IL-2
    • Houston, Texas
    • +1 more
    Apr 3, 2018

    MDS, AML, ALL Trial in France (Clofarabine in combination with IV busulfan and ATG)

    Completed
    • MDS
    • +3 more
    • Clofarabine in combination with IV busulfan and ATG
    • Lyon, France
    • +5 more
    Jul 18, 2017

    All Trial in Boston (Re-Engineered Hospital Discharge)

    Completed
    • All
    • Re-Engineered Hospital Discharge
    • Boston, Massachusetts
      Boston Medical center
    Feb 27, 2017

    Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)

    Terminated
    • Hematologic Malignancy
    • +11 more
    • Total Body Irradiation (TBI)
    • +5 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Oct 19, 2016

    CML, AML, MDS Trial in Philadelphia (Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells, Observation Arm)

    Completed
    • CML
    • +6 more
    • Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
    • Observation Arm
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 17, 2016

    AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

    Completed
    • AML
    • +8 more
    • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jul 14, 2016

    AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)

    Completed
    • AML
    • +4 more
    • TG02 citrate
    • +2 more
    • Denver, Colorado
    • +8 more
    May 5, 2016

    Photochemotherapy and Graft-versus-leukemia in Acute-leukemia

    Completed
    • ALL
    • +3 more
    • Photochemotherapy
    • Stockholm, Sweden
      Department of Dermatology, Karolinska University Hospital Huddin
    Dec 11, 2015

    ALL Trial in Boston (Music Therapy, Massage Therapy)

    Completed
    • ALL
    • Music Therapy
    • Massage Therapy
    • Boston, Massachusetts
      Boston Medical Center
    Jan 27, 2015

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Blast-phase Chronic Myelogenous Leukemia Trial in Tampa, Baltimore, Durham

    Completed
    • Acute Myeloid Leukemia
    • +5 more
    • STA-9090 (ganetespib)
    • Tampa, Florida
    • +2 more
    Sep 17, 2014

    ALL, ANLL, MDS Trial (Naive T-cell Depleted Stem Cell Transplant, Stem Cell Transplant No Manipulation, Isolex device from

    Terminated
    • ALL
    • +3 more
    • Naive T-cell Depleted Stem Cell Transplant
    • +2 more
    • (no location specified)
    Sep 25, 2013

    Unrelated Stem Cell Transplantation for Hematopoietic Disorders

    Completed
    • CML
    • +5 more
      • San Francisco, California
        University of California San Francisco
      Aug 1, 2013

      Hematologic Malignancy, AML, ALL Trial in Boston (CD+8 T cell depletion)

      Completed
      • Hematologic Malignancy
      • +6 more
      • CD+8 T cell depletion
      • Boston, Massachusetts
      • +1 more
      Mar 15, 2012

      AML, MDS, ALL Trial in Seoul (fludarabine phosphate, busulfan)

      Unknown status
      • AML
      • +4 more
      • fludarabine phosphate, busulfan
      • Seoul, Korea, Republic of
        Dong Hwan Kim
      Dec 29, 2008